tyrosine and Constriction, Pathologic

tyrosine has been researched along with Constriction, Pathologic in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (14.29)	18.2507
2000's	5 (71.43)	29.6817
2010's	1 (14.29)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Areti, A; Gogoi, R; Komirishetty, P; Kumar, A; Ruby, PK; Sharma, SS; Sistla, R; Yerra, VG	1
Aladag, MA; Egri, M; Ozen, H; Parlakpinar, H; Turkoz, Y; Unal, SC	1
Chiariello, M; D'andrea, C; Esposito, G; Piscione, F	1
Danilovic, A; Dantas, AP; Dantas, K; Laurindo, FR; Leite, PF; Marklund, S; Moriel, P	1
Colucci, WS; Kotlyar, E; Kuster, GM; Liao, R; Rude, MK; Sam, F; Siwik, DA	1
Tcheng, JE	1
Banai, S; Chorny, M; Fishbein, I; Gazit, A; Gertz, SD; Golomb, G; Huber, R; Levitzki, A; Mayr, U; Rabinovich, L; Waltenberger, J	1

Reviews

1 review(s) available for tyrosine and Constriction, Pathologic

Article	Year
Glycoprotein IIb/IIIa receptor inhibitors: putting the EPIC, IMPACT II, RESTORE, and EPILOG trials into perspective. The American journal of cardiology, 1996, Aug-14, Volume: 78, Issue:3A Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Atherectomy, Coronary; Constriction, Pathologic; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Recurrence; Stents; Tirofiban; Treatment Outcome; Tyrosine	1996

Article

Year

Glycoprotein IIb/IIIa receptor inhibitors: putting the EPIC, IMPACT II, RESTORE, and EPILOG trials into perspective.

The American journal of cardiology, 1996, Aug-14, Volume: 78, Issue:3A

Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Atherectomy, Coronary; Constriction, Pathologic; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Recurrence; Stents; Tirofiban; Treatment Outcome; Tyrosine

1996

Other Studies

6 other study(ies) available for tyrosine and Constriction, Pathologic

Article	Year
PARP inhibition attenuates neuroinflammation and oxidative stress in chronic constriction injury induced peripheral neuropathy. Life sciences, 2016, Apr-01, Volume: 150 Topics: Animals; Benzamides; Constriction, Pathologic; Cyclooxygenase 2; Hyperalgesia; Inflammation; Male; NAD; Neuritis; Neuroprotective Agents; Oxidative Stress; Pain Measurement; Peripheral Nervous System Diseases; Poly(ADP-ribose) Polymerase Inhibitors; Rats; Rats, Sprague-Dawley; Sensation; Tyrosine; Walking	2016
Melatonin ameliorates cerebral vasospasm after experimental subarachnoidal haemorrhage correcting imbalance of nitric oxide levels in rats. Neurochemical research, 2009, Volume: 34, Issue:11 Topics: Animals; Antioxidants; Arginase; Basilar Artery; Brain; Constriction, Pathologic; Free Radicals; Immunohistochemistry; Male; Melatonin; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Rats; Rats, Wistar; Subarachnoid Hemorrhage; Superoxide Dismutase; Tyrosine; Vasospasm, Intracranial	2009
Tirofiban administration and percutaneous coronary intervention with stenting of saphenous vein graft thrombosis. Journal of cardiovascular medicine (Hagerstown, Md.), 2009, Volume: 10, Issue:11 Topics: Aged, 80 and over; Angioplasty, Balloon, Coronary; Constriction, Pathologic; Coronary Angiography; Coronary Artery Bypass; Drug Administration Schedule; Embolism; Fibrinolytic Agents; Graft Occlusion, Vascular; Humans; Male; Saphenous Vein; Stents; Thrombosis; Tirofiban; Treatment Outcome; Tyrosine	2009
Sustained decrease in superoxide dismutase activity underlies constrictive remodeling after balloon injury in rabbits. Arteriosclerosis, thrombosis, and vascular biology, 2003, Volume: 23, Issue:12 Topics: Animals; Catheterization; Constriction, Pathologic; Dilatation, Pathologic; Down-Regulation; Iliac Artery; Neovascularization, Pathologic; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Oxidative Stress; Rabbits; Superoxide Dismutase; Tunica Intima; Tunica Media; Tyrosine	2003
Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload. Circulation, 2005, Feb-01, Volume: 111, Issue:4 Topics: Animals; Aorta; Apoptosis; Blood Pressure; Cell Size; Chronic Disease; Constriction, Pathologic; Drug Evaluation, Preclinical; Eplerenone; Fibrosis; Heart Failure; Hypertrophy, Left Ventricular; Intercellular Adhesion Molecule-1; Ligation; Male; Matrix Metalloproteinases; Mice; Mineralocorticoid Receptor Antagonists; Myocarditis; Myocardium; Myocytes, Cardiac; Oxidative Stress; Pressure; Random Allocation; Receptors, Mineralocorticoid; Spironolactone; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Tyrosine	2005
Local delivery of platelet-derived growth factor receptor-specific tyrphostin inhibits neointimal formation in rats. Arteriosclerosis, thrombosis, and vascular biology, 2000, Volume: 20, Issue:3 Topics: Angioplasty, Balloon; Animals; Aorta; Arteries; Carotid Arteries; Cell Division; Cell Survival; Cells, Cultured; Constriction, Pathologic; Enzyme Inhibitors; Male; Muscle, Smooth, Vascular; Phosphorylation; Protein-Tyrosine Kinases; Rats; Rats, Inbred Strains; Receptor, Platelet-Derived Growth Factor beta; Recurrence; Tunica Intima; Tyrosine; Tyrphostins; Up-Regulation	2000